Registered Trials
-
NCT05313035
Phase 2/3Indonesia
Total Enrollment: 3,960
Official Trial Registration:
-
NCT05067894
Phase 1/2Indonesia
Total Enrollment: 780
Official Trial Registration:
Vaccine Type: Protein Subunit
This vaccine has reached Phase 3 trials.
This vaccine is not yet approved.
Indonesia
Total Enrollment: 3,960
Indonesia
Total Enrollment: 780
© 2022 VIPER Group COVID19 Vaccine Tracker Team
Funding provided by the McGill University Interdisciplinary Initiative in Infection and Immunity (MI4)
This site is provided for informational purposes only based on publically available data.